Objects
Dowse, Roslind, Haigh, John M, Kanfer, Isadore. Pharmacokinetics of phenylpropanolamine in humans after a single dose study. 1987.
Kanfer, Isadore, Haigh, John M, Dowse, Roslind. Phenylpropanolamine hydrochloride. .
Dowse, Roslind, Haigh, John M, Kanfer, Isadore. In vitro-in vivo evaluation of a sustained release phenylpropanolamine oral dosage form. 1982.
Dowse, Roslind, Haigh, John M, Kanfer, Isadore. Determination of phenylpropanolamine in serum and urine by high performance liquid chromatography. 1983.
Smith, Eric W, Walker, Roderick B, Haigh, John M, Kanfer, Isadore. Evaluation of the proposed FDA pilot-dose response methodology for topical corticosteroid bioeqivalence testing [authors' reply in Letters to the Editor]. 1998.
Demana, Patrick H, Smith, Eric W, Walker, Roderick B, Haigh, John M, Kanfer, Isadore. Evaluation of the proposed FDA pilot-dose response methodology for topical corticosteroid bioequivalence testing. 1997.
Haigh, John M, Meyer, Eric, Smith, Eric W, Kanfer, Isadore. The human skin blanching assay for in vivo topical corticosteroid assessment. II. Subject- and observer-dependent variation in blanching responses. 1997.
Magnus, Ashley D, Haigh, John M, Kanfer, Isadore. Assessment of some variables affecting the blanching activity of betamethasone 17-valerate cream. 1980.
Meyer, Eric, Magnus, Ashley D, Haigh, John M, Kanfer, Isadore. Comparison of the blanching activities of Dermovate, Betnovate and Eumovate creams and ointments. 1988.
Stubbs, Christopher, Haigh, John M, Kanfer, Isadore. High performance liquid chromatographic analysis of oleandomycin in serum and urine. 1986.
Gochin, Rosa, Kanfer, Isadore, Haigh, John M. The simultaneous determination of trimethoprim, sulphamethoxazole and N4-acetylsulphamethoxazole in biological fluids by high pressure liquid chromatography. 1981.
Smith, Eric W, Haigh, John M, Kanfer, Isadore. A stability-indicating HPLC assay with on-line clean-up for betamethasone 17-valerate in topical dosage forms. 1985.
Meyer, Eric, Haigh, John M, Kanfer, Isadore. Comparative bioavailability of some locally manufactured betamethasone valerate containing preparations. 1983.
Meyer, I, Kanfer, Isadore, Haigh, John M. Comparative blanching activities of some topical corticosteroid containing lotions. 1981.
Stubbs, Christopher, Haigh, John M, Kanfer, Isadore. Determination of erythromycin in serum and urine by high performance liquid chromatography with ultraviolet detection. 1985.
Haigh, John M, Kanfer, Isadore, Meyer, Eric, Smith, Eric W. Relative potencies of topical corticosteroid formulations. 1985.
Meyer, Eric, Smith, Eric W, Haigh, John M, Kanfer, Isadore. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilizing the human skin-blanching assay. 1988.
Coleman, Gerald L, Kanfer, Isadore, Haigh, John M. Comparative blanching activities of proprietary diflucortolone valerate topical preparations. 1978.
Magnus, Ashley D, Haigh, John M, Kanfer, Isadore. The release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream. 1981.
Haigh, John M, Kanfer, Isadore, Meyer, Eric, Smith, Eric W. Reply to correspondence: P.M. Gaylarde (1986) The human skin blanching assay—use and abuse. 1986.
Stubbs, Christopher, Haigh, John M, Kanfer, Isadore. A stability-indicating liquid chromatographic method for the analysis of erythromycin in stored biological fluids using amperometric detection. 1987.
Haigh, John M, Kanfer, Isadore. Assessment of topical corticosteroid preparations: the human skin-blanching assay. 1984.
Smith, Eric W, Haigh, John M. Precision of tristimulus chromameter results from corticosteroid-induced skin blanching. 1998.
Schwarb, Fabian P, Imanidis, Georgios, Smith, Eric W, Haigh, John M, Surber, Christian. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. 1999.
Schwarb, Fabian P, Smith, Eric W, Haigh, John M, Surber, Christian. Chromametry: measuring precision of diurnal and local variation of human forearm skin colour. 1998.
Haigh, John M, Smith, Eric W, Maibach, Howard I. New developments in the methodology available for the assessment of topical corticosteroid-induced skin blanching. 1998.
Schwarb, Fabian P, Smith, Eric W, Haigh, John M, Surber, Christian. Analysis of chromameter results obtained from corticosteroid-induced skin blanching assay: comparison of visual and chromameter data. 1999.
Haigh, John M, Smith, Eric W. The requirements for accurate analysis of pharmaceutical research at South African Universities. 1998.
Smith, Eric W, Haigh, John M, Surber, Christian. Quantification of corticosteroid-induced skin vasoconstriction: visual ranking, chromameter measurement or digital image analysis. 2002.
Schwarb, Fabian P, Smith, Eric W, Haigh, John M, Surber, Christian. Bioequivalence testing of topical dermatological formulations, the gap between science and legislation. 1998.
Haigh, John M, Beyssac, E, Chanet, L, Aiache, J M. In vitro permeation of progesterone from a gel through the shed skin of three different snake species. 1998.
Purdon, Carryn H, Haigh, John M, Surber, Christian, Smith, Eric W. Foam drug delivery in dermatology: beyond the scalp. 2003.
Pefile, S C, Haigh, John M, Smith, Eric W. The use of supersaturated solutions for the percutaneous delivery of rooperol tetra-acetate. 1998.
Smith, Eric W, Haigh, John M. In vitro diffusion cell design and validation. I. A stability-indicating high-performance liquid chromatographic assay for betamethasone 17-valerate in purified isopropyl myristate receptor phase. 1989.
Haigh, John M, Meyer, Eric, Smith, Eric W, Kanfer, Isadore. The human skin-blanching assay for in vitro topical corticosteroid assessment. I. Reproducibility of the assay. 1997.
Smith, Eric W, Haigh, John M. Ranking of topical corticosteroids: principles and results. 1993.
Haigh, John M, Smith, Eric W. Topical corticosteroid-induced skin blanching measurement, eye or instrument?. 1991.
Smith, Eric W, Meyer, Eric, Haigh, John M, Maibach, Harold I. The human skin-blanching assay for comparing topical corticosteroid availability. 1991.
Rodgers, A L, Nassimbeni, L R, Pauptit, R A, Orpen, G, Haigh, John M. The structure of aliphatic amine adducts of uranyl acetylacetonate. IV. Dioxobis(2,4-pentanedionato) mono(2-aminopentan-4-one)uranium(VI). 1977.
Haigh, John M. Dilution of topical corticosteroid formulations. 1988.
Woodford, R, Haigh, John M, Barry, B W. Le test de McKenzie-Stoughton: méthode de mesure de l’effect réservoir. 1981.
Nassimbeni, L R, Orpen, G, Pauptit, R A, Rodgers, Allen L, Haigh, John M. The structure of aliphatic amine adducts of uranyl acetylacetonate. II. Dioxobis(2,4-pentanedionato)mono (2-N,N-dimethylaminopentan-4-one)uranium(VI). 1977.
Haigh, John M, Van Dam, M A, Thornton, D A. Complexes of mercury(II) and zinc(II) with primary aromatic amines. 1967.
Smith, Eric W, Haigh, John M. In vitro diffusion cell design and validation. II. Temperature, agitation and membrane effects on betamethasone 17-valerate permeation. 1992.
Smith, Eric W, Meyer, Eric, Haigh, John M, Maibach, Harold I. The human skin-blanching assay as an indicator of topical corticosteroid bioavailability and potency: an update. 1989.
Smith, Eric W, Meyer, Eric, Haigh, John M. Blanching activities of betamethasone 17-valerate formulations: effect of the dosage form on topical drug availability. 1990.
Smith, Eric W, Haigh, John M. In vitro systems for the assessment of drug release from topical formulations and trans-membrane permeation. 1989.
Haigh, John M, Smith, Eric W. The selection and use of natural and synthetic membranes for in vitro diffusion experiments. 1994.
Smith, Eric W, Haigh, John M. In vitro release of propranolol hydrochloride from topical vehicles. 1994.
Smith, Eric W, Haigh, John M. Assessing penetration enhances for topical corticosteroids. 1995.
Smith, Eric W, Meyer, Eric, Haigh, John M. Accuracy and reproducibility of the multiple-reading skin blanching assay. 1992.
Haigh, John M, Smith, Eric W. The effects of elevated and ambient temperature conditions on dilutions of fluocinolone acetonide ointment assessed using the human skin-blanching assay. 1995.
Meyer, Eric, Smith, Eric W, Haigh, John M. Sensitivity of different areas of the flexor aspect of the human forearm to corticosteroid-induced skin blanching. 1992.
Smith, Eric W, Haigh, John M. In vivo/in vitro assessments of topical hydrocortisone availability: correlation between blanching assay and laboratory cell experiments. 1995.
Walker, Roderick B, Haigh, John M, Smith, Eric W. Application of the Minolta chromameter to the assessment of corticosteroid-induced skin blanching. 2000.
Smith, Eric W, Haigh, John M, Walker, Roderick B. Analysis of chromameter results obtained from corticosteroid-induced skin blanching. I. Manipulation of data. 1998.
Schwarb, Fabian P, Smith, Eric W, Haigh, John M, Surber, Christian. Comparison of visual CR-200 and CR-300 chromameter data obtained from the corticosteroid-induced skin-blanching assay. 1998.
Haigh, John M, Beyssac, E, Aiache, J M. Can shed snakeskin be considered to be a model membrane for human stratum corneum?. 1998.
Haigh, John M, Smith, Eric W. The registration of generic topical corticosteroid formulations in South Africa: a report. .
Woodford, R, Haigh, John M. Bioavailability and activity of 0.1% amcinonide preparations: comparison with proprietary topical corticosteroid formulations of differing potencies. 1979.
Rodgers, A L, Nassimbeni, L R, Haigh, John M. The structure of aliphatic amine adducts of uranyl acetylacetonate. III. Dioxobis(2,4-pentanedionato)mono (2-N-isopropylaminopentan-4-one)uranium(VI). 1977.
Haigh, John M. Ligand substitution effects in uranyl ο-hydroxyarylcarbonyl complexes. 1974.
Woodford, R, Haigh, John M, Barry, B W. Possible dosage regimens for topical steroids assessed by vasoconstrictor assays using multiple applications. 1983.
Woodford, R, Haigh, John M, Barry, B W. Résultats des études menées en Angleterre: détermination de la posologie optimale. 1981.
Haigh, John M, Nassimbeni, Luigi R, Pauptit, Richard A, Rodgers, Allen L, Sheldrick, George M. The structure of aliphatic amine adducts of uranyl acetylacetonate. I. Dioxobis(2,4-pentanedionato)mono (2-N-methylaminopentan-4-one)uranium(VI). 1976.
Nassimbeni, L R, Rodgers, Allen L, Haigh, John M. The crystal and molecular structure of the bis(4-N, N1-dimethylaminopyridine) solvate of disalicylicacidatobis(nitrotodioxouranium)(VI). 1976.
Haigh, John M, Van Dam, M A, Thornton, D A. Complexes of zinc, cadmium and mercury with primary aromatic amines. 1967.
Haigh, John M, Van Dam, M A, Thornton, D A. Infrared evidence for the transmission of electronic effects through a metal atom in a series of new cadmium complexes. 1967.